Ocugen has a deal with India-based Bharat Biotech to bring that company’s Covaxin Covid-19 vaccine candidate to the United States. Housing Industry Calls for U.S. Action on ‘Skyrocketing’ Lumber, Ocugen Stock May Have One More Rally in It Before It’s Over, Third stimulus check and more: 7 ways to get money from the new COVID law, Is your income just over the threshold for the $1,400 stimulus check? Moderna spiked when it began to work on its Covid-19 vaccine. The front end of dollar funding markets has remained relatively anchored of late with a flood of dollars and supply-demand imbalances in various money markets exerting downward pressure on rates, and even driving levels on repurchase agreements below zero.With Friday’s sudden spike, Treasury yields across the long end exceeded levels seen after the disastrous seven-year U.S. bond auction from Feb. 25. system predicted the March 2020 crash…Now it says all Americans should do one thing before April. The company is headquartered in Cambridge, Massachusetts with an R&D center in Suzhou, China. After cutting advertising and axing 400 jobs unsuited to home-work, the Tysons Corner, Virginia-based firm was sitting on a cash pile of $550 million with nowhere to put it. The presentation will be accessible via a live webcast at: https://jpmorgan.metameetings.net/events/healthcare21/sessions/35931-kira-pharmaceuticals/webcast?gpu_only=true&kiosk=true. (Bloomberg) -- It’s the latest corporate strategy for companies from Tesla Inc. to Square Inc.: shift a portion of cash reserves into cryptocurrencies as digital assets become more mainstream.Still, few have gone as far as MicroStrategy Inc. On Friday, Saylor tweeted that MicroStrategy bought 262 additional Bitcoins for $15 million in cash, bringing the total to about 91,326. What happens if Covaxin doesn’t get a green light from the FDA? and SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted … The company is headquartered in Cambridge, Massachusetts with an R&D … "The reclassification of employees as independent contractors, or the use of independent contracting relationships as opposed to employment, decreases access to employer-provided fringe benefits such as health care or retirement benefits," it said in one section. CAMBRIDGE, MA and SUZHOU, JIANGSU (February 2, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, announced today that the first healthy volunteer has been successfully dosed in a first-in-human Phase 1 clinical trial for its lead investigational therapy P014. Right now, borrowers who have their student loans discharged — with a few exceptions, including through Public Service Loan Forgiveness — face a tax bill on the cancelled debt. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Binance takes its compliance obligations “very seriously,” the company said. The $1.9 trillion package includes multiple forms of aid for U.S. households. An unstoppable force is taking over our financial markets. With offices in Cambridge, Massachusetts and an R&D … The Biden administration is not proposing an immediate substitute, which means previous rules are back in effect. Kira Pharmaceuticals is a biotechnology company developing complement-targeted therapies to treat immune-mediated diseases. The speed and severity of the move left many traders perplexed, with volumes in the cash market comparatively modest.The moves there were most pronounced in some of the longer tenor securities, with the yield curve steepening as two-year rates rose less than two basis points. And that’s after pulling back some 46% from its highs set last month. He is also an Associate Clinical Professor at UCLA. "We are pleased to welcome Frederick at a critical time for the organization. When the majority of MicroStrategy’s cash reserves were exhausted, Saylor raised a $650 million corporate bond and used it to buy more.Saylor said he’d rather issue debt against future cash flow now than save up to buy Bitcoin in five years, when he thinks it’ll be pricier.In February, the company raised another $1.05 billion in a bonds-for-Bitcoin offering, and on March 5 it announced yet more purchases. Dr. Beddingfield is board certified in Dermatology, Mohs Micrographic Surgery, Cutaneous Oncology and Emergency Medicine. Residents Traded, "Little-Known Tech" Behind Electric Vehicle Boom, Stimulus checks sent to wrong bank accounts for some Americans checking IRS ‘Get My Payment’ tool, Nancy Pelosi’s Husband Bought Up This Investment Firm’s Stock, When will I get my third stimulus check? So, if Covaxin is a bust, OCGN stock will head fast back towards its prior price levels. Most recently, Dr. Beddingfield was founder and CEO of Sienna Biopharmaceuticals, a company developing topical and systemic therapies for inflammatory and immune-mediated skin diseases. While the firm has been transparent about this change in regulatory disclosures, juggling two distinct goals isn’t something that investors are accustomed to.“If you’re a hedge fund and you want to make that kind of a concentrated bet, you’re entitled to do that,” Lichtenfeld said, but “as a software company to make this kind of a bet is completely irresponsible.”‘Critical Point’Saylor said the company has been upfront with investors throughout. That means Elon Musk's bet on the cryptocurrency has netted Tesla more than a billion dollars. All rights reserved. "This drug discovery platform is based on technology and animal models licensed from the University of Pennsylvania and I am very pleased to see this effort to translate our research findings into medicine for patients in need," said Wenchao Song, PhD, scientific co-founder and Chair of the Scientific Advisory Board of Kira Pharmaceuticals. The COVID-19 relief bill that President Joe Biden signed into law eliminates an obstacle to broad-based student debt cancellation — the tax treatment of any discharged debt. Enabled by its LOGIC drug discovery platform, the company is committed to advancing first-in-class and best-in-class therapies to transform the lives of patients with complement-driven diseases. “We potentially could grow a lot faster and inflation could come into the horizon a lot quicker,” which begets higher rates.The breakeven rate on 10-year notes, a measure of market expectations for annual consumer-price gains based on the yield gap to inflation-linked debt, topped 2.30% in early New York trading Friday, a level it hasn’t breached since early 2014. More articles by John Kingston New federal rule on worker classification may not see light of day Labor Department tackles employee classification; AB5 may not be affected PRO Act with its ABC test approved in House See more from BenzingaClick here for options trades from BenzingaIncreasingly Difficult Yearly Comps Are A Distraction; The Market Is RollingPPP Money Flowing To Transportation, Warehousing At Same Rate As Before© 2021 Benzinga.com. While there’s an opportunity here for another short-term spike, this long-shot vaccine play remains very speculative. That’ll keep the average lumber price this year above levels seen in 2020, he said.The surge in lumber demand initially took the industry by surprise in mid-2020 as the pandemic fueled a flurry of home renovations while homebuilding soared. What’s the best move? Here’s what’s coming. Paul Pelosi, husband of Speaker Nancy Pelosi, bought more than $1 million of shares of investment firm AllianceBernstein in February. Accompanying the several weeks of walking back from the Trump rule were withdrawals of various opinion letters that had used the proposed independent contractor rule as the basis. The tests include such provisions as the level of control the employer has over the worker and the "degree of permanence" in the job. Even with the $23 million in proceeds from its recent direct offering, Ocugen still doesn’t have the balance sheet to support that lofty number, either. Dr. Beddingfield joins Kira with nearly 20 years of biopharma experience. Norman Chen Venture Partner, 6 Dimensions Capital Frank Kung … The Wage and Hour Division of the Department of Labor announced Thursday it was withdrawing the rule that had been announced by the Trump administration's WHD in its waning days. The WHD first announced in February it was considering delaying the rule that was to go into effect in March, then delayed to May and now has withdrawn it. The crypto behemoth has been attracting more than 300,000 user registrations a day, exceeding its previous peak reached in 2017, Zhao told Bloomberg TV last month.In the U.S., that kind of growth often attracts attention from regulators and law-enforcement agencies that are concerned about illegal trading, manipulation, money laundering and sanctions violations.Government ChargesIn October, the CFTC sued Seychelles-based BitMEX in federal court for allegedly letting Americans trade crypto derivatives and not registering with the agency as a brokerage, among misconduct. But, those looking to go long today should exercise some caution as well. Bitcoin is struggling to break above its current all-time high set in mid February. View original content to download multimedia:http://www.prnewswire.com/news-releases/kira-pharmaceuticals-launches-to-pioneer-novel-therapeutics-for-complement-mediated-diseases-301171704.html. Speaking during an event on the social media platform Clubhouse, he declined to comment on whether the CFTC is investigating Binance.“We’ll continue to improve our compliance,” Zhao said. Wu serves on the board of Crescendo Biologics, Kira Pharmaceutical and Qiagen (Suzhou) Translational Medicine Co., Ltd. She was a board member of Zai Lab Limited (NASDAQ: ZLAB), Taiwan Liposome Company (GTSM: 4152), JHL Biotech (TWEM: 6540), and General Biologics Corporation (TWEM: 4117). Kira Pharmaceuticals is a biotechnology company developing complement-targeted therapies to treat immune-mediated diseases. Enabled by its LOGIC drug discovery platform, the company is committed to advancing first-in-class and best-in-class therapies to transform the lives of patients with complement-driven diseases. In documents recently filed with the U.S. Securities and Exchange Commission ahead of a planned initial public offering, Coinbase said it competes with firms with “varying degrees of regulatory adherence, such as Binance.”(Updates with comment from Baucus in 13th paragraph. Eight months after its first investment, the software firm has a Bitcoin holding worth more than $5 billion.Shares of MicroStrategy have rocketed almost 600% since mid-July, boosting the fortune of founder Michael Saylor, a billionaire until an accounting scandal in 2000. Kira is backed by a syndicate of leading global life science venture firms including Quan Capital, 6 Dimensions Capital, Qiming Venture Partners, and Sinopharm Capital and plans to rapidly advance a pipeline of novel therapies designed to achieve better, longer lasting immune modulation. Sure, as is the case with other long-shot vaccine plays, the company has other candidates in its pipeline. https://jpmorgan.metameetings.net/events/healthcare21/sessions/35931-kira-pharmaceuticals/webcast?gpu_only=true&kiosk=true. "Withdrawal of the rule would allow WHD an additional opportunity to consider legal and policy issues related to the FLSA and independent contractors." and SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced $46M in investments secured to date and the appointment of Frederick Beddingfield, MD, PhD as Chief Executive Officer.Kira is backed by a syndicate of leading … BitMEX’s founders were separately charged criminally by the Justice Department with violating U.S. laws meant to prevent money laundering, a claim also made by the CFTC.In a statement after the actions were filed, BitMEX said it strongly disagreed with the accusations and that it has always sought to comply with U.S. laws. ", "Kira's founding team has developed an intelligent drug discovery platform driving the development of novel compounds with the ability to overcome the challenges of complement drug discovery and modulate the complement system in new and thoughtful ways," said Dr. Beddingfield, CEO, Kira Pharmaceuticals. The market’s worry is that such a move could lead to a very steep yield curve as the Fed looks past short-term spikes in inflation and growth, he added.Australian SparkThe move in global debt started in Australia, where bond futures fell heading into the market’s close to put modest pressure on Treasuries. Kira Pharmaceuticals is a biotechnology company developing complement-targeted therapies to treat immune-mediated diseases. That’s what happened with names like Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX). Founding Date: 2017: Kira Pharmaceuticals: total Funding$99.5 m: Kira Pharmaceuticals: latest funding size$53.50 m: Time since last funding : a month ago: Kira Pharmaceuticals: investorsTencent, Qiming … But that said, while there’s a chance for nimble traders to make some fast gains, this is still a big gamble. “We’ll also work very actively with regulators around the world to improve the compliance standards of the industry.”Binance said in an earlier statement Thursday that it blocks U.S. residents from its website and uses advanced technology to analyze deposits and withdrawals for signs of illicit transactions. Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016. )For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P. Bitcoin prices head for a sharp weekly rise on Friday, even as the cryptocurrency was facing some negative headlines tied to a major trading platform. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. China has also increased its appetite for lumber, and FEA forecasts the Asian nation will need to boost imports by around 14%.“There’s not going to be enough fiber to supply global demand for saw timber over the next decade,” Jannke said, adding that only the southern U.S. and Russia have significant amounts of excess timber. CAMBRIDGE, MA and SUZHOU, China (January 12, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced that Frederick Beddingfield, Chief Executive Officer of Kira Pharmaceuticals, will present at the Virtual 39th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13, 2021 at 11:35 AM ET. Kira Biotech is an emerging Australian biotechnology company developing novel immunomodulatory compounds for the treatment of immune system disorders. If you've got more than $1,000 in your checking account, you need to make these moves as fast as possible. It was down 1.6% to $56.685.02 as of 4:17 pm New York time.The investigation adds to the U.S.’s growing crackdown on crypto. Benzinga does not provide investment advice. The Trump administration's WHD released guidance letters based on the proposed rule as late as just a few days before President Joe Biden took office. System Predicts Crash Before April, Treasury Yields Leap Past Key Level to 1.64%, Highest in a Year, Bitcoin hit an all-time high — Here's why Warren Buffett still won't touch it, COVID-19 Relief: Time your taxes or you could miss out on stimulus check money. Soaring prices for wood have lifted the average price of a new single-family home in the U.S. by more than $24,000 since April, according to the National Association of Home Builders.Lumber prices have nearly tripled while those for boards used in residential construction have jumped more than 250% since last spring, according to the letter.“Home builders and construction firms that have signed fixed-price contracts are forced to absorb these crippling increases in materials prices and costly delays in deliveries,” the letter said, adding that “there is a significant risk that many of these firms will be forced out of business.”Costs that can be passed on will make housing less affordable, the letter said, while “other projects will no longer be economically viable, which undercuts the availability of new housing supply and further jeopardizes affordability.”No ReliefNorth American lumber prices are expected to extend gains through this year as homebuilding and renovations cause demand for wood to outstrip production, according to forecasts by Forest Economic Advisors LLC.“Production is going to have a hard time keeping up with demand growth as the world economy bounces back from Covid-19 in 2021-22,” Paul Jannke, the FEA’s principal of lumber, said Thursday during a conference hosted by the industry research group. In a move that had numerous precursors to its ultimate implementation, the Biden administration has formally withdrawn a Trump administration rule on the definition of independent contractors under the Fair Labor Standards Act. Nord Pool now settles its daily prices about 30 minutes before Epex.Traders “are happy to try and use the new arrangements to their advantage,” said Phil Hewitt, a director at energy consultancy Enappsys Ltd. “Getting a good spread between the two auctions is good if you call it right, you can book healthy profits in 30 minutes.”Epex has about a third of the trading volume and the participants tend to be small traders and asset providers, while Nord Pool members are usually larger and more well established, Hewitt said. Kira's most advanced program, P014, is a first-in-class biologic drug with a unique mechanism of action designed to inhibit both upstream and downstream complement targets. At around the same time, there was a block sale of 10-year ultra bond futures, followed by a buyer of downside put options -- the hedging of which tends to weigh on the market. The three combined to tip 10-year Treasury futures through Thursday’s session low, which unleashed a wave of selling.As many as 20,000 contracts changed hands in the next five minutes, the largest activity of the day to that point. CAMBRIDGE, Mass. Coinbase Global Inc., the U.S.’s biggest crypto exchange, also disclosed last month that it’s responding to a wide-ranging CFTC probe. That is the environment that led us to decide we should consider Bitcoin as a treasury reserve asset.”‘Every Scar’Not everyone agrees with the strategy.“Saylor equated Bitcoin to a bank – that’s just ridiculous,” said Marc Lichtenfeld, chief income strategist at the Oxford Club, a financial-research firm that has no stake in MicroStrategy. CAMBRIDGE, Md. There could be further increases ahead as the housing sector braces for homebuying season. The CFTC declined to comment.Bitcoin fell after news of the Binance investigation was reported. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now The post Ocugen Stock May Have One More Rally in It Before It’s Over appeared first on InvestorPlace. Maybe not back to that 52-week low of 17 cents per share. 'There are only two tax codes in the world: One for the informed and one for the uniformed,' one adviser says. The price for the same contract should be the identical but the difference can be as much as 500 pounds ($697) per megawatt-hour, a seven-fold increase over the average next-day rate.Using two auctions creates a market inefficiency that increases costs for consumers. ORGANIZING COMMITTEE . Those who got in early have made tremendous profits. (Bloomberg) -- Soaring lumber prices and chronic shortages are prompting key U.S. housing industry participants to call on the Biden administration to find remedies that’ll boost wood production.Thirty-seven organizations are calling for the “immediate attention” of U.S. Department of Commerce Secretary Gina Raimondo to address “skyrocketing” lumber prices and supply constraints they say endanger economic recovery and housing affordability.“We respectfully request that your office examine the lumber supply chain, identify the causes for high prices and supply constraints, and seek immediate remedies that will increase production,” according to a March 12 letter signed by groups involved in areas of housing including construction, real estate and manufacturing.The pleas come as higher prices for wood threaten to stifle the number of planned construction projects across North America and push prices for new homes even higher due to rising costs, exacerbating woes faced by new homebuyers in the past year. The 30-year rate advanced almost 11 basis points to a session high of 2.40%, edging toward a January 2020 peak. But, likely much closer to that than where shares change hands today. In comments last week, Fed Chairman Jerome Powell did note the recent shift up in bond yields, but said little to indicate that officials are willing to push back against it at this stage.“The bond market is seeking a new equilibrium in the light of a vastly improved economic outlook in both the U.S. and elsewhere,” said Kit Juckes, chief currency strategist at Societe Generale SA. The contract, which averaged around $456 last year, was at $972 on Thursday.Renovation activity is expected to stay “extremely strong,” according to Brendan Lowney, principal of macroeconomics at FEA. With offices in Cambridge, Massachusetts and an R&D … “Every scar informs you, and I wouldn’t be who I am without having lived through those experiences.”Steady RevenueSaylor has continued to run the analytics software business he founded in 1989, and has overseen annual revenue streams of around $500 million for the last decade, though sales have dipped in recent years.Bitcoin’s price has soared in recent months, hitting a record above $58,000 last month as big investors pile in and the asset class matures.Saylor shrugs off concern about Bitcoin’s volatility and said crypto critics are behind the curve. Enabled by its LOGIC drug discovery platform, the company is committed to advancing first-in-class and best-in-class therapies to transform the lives of patients with complement-driven diseases. So, putting it simply, it’s too early to bet against this name. With offices in Cambridge, Massachusetts and an R&D center in Suzhou, China, Kira Pharmaceuticals is committed to establishing a global footprint and advancing life-changing therapies to patients around the world. It was replaced by a Trump administration economic realities test that took two of the provisions and elevated them to "core factors": an employee's degree of control over the work and the worker's opportunity to profit if he or she showed initiative and drive. It also won’t take much to send it falling back towards prior price levels. “We find it hard to see where this fiber’s going to come from.”(Adds details of industry letter in first three paragraphs. http://www.prnewswire.com/news-releases/kira-pharmaceuticals-launches-to-pioneer-novel-therapeutics-for-complement-mediated-diseases-301171704.html, Merkel’s Party Slumps to Historic Low in German State Elections, Merkel's CDU thumped in state votes, hurting her would-be successor, Yellen Says U.S. Inflation Risk Remains Small, ‘Manageable’, Global Central Banks Confront Enthusiasm of Investors: Eco Week, Box Office: 'Raya and the Last Dragon' Repeats No. CAMBRIDGE, Mass. But what does it mean for those considering a position right now, at around $10 per share? Kira Pharmaceuticals Biotechnology Cambridge, MA 279 followers Pioneering complement drug discovery to deliver transformative therapies for people with complement-mediated diseases Right now, OCGN has a market capitalization of $1.88 billion. But as the WHD notes, the economic realities tests have several components, none of which are more important than others. For more information, please visit www.kirapharma.com. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders, Kathy He, Richard Lee, MD, and Dana Zhang, MD, to its expanding team. Any sort of additional progress regarding Covaxin will produce another spike for OCGN stock. Ocugen Could Rally Once More, But It’s Still a Big Gamble All told, I remain skeptical on this speculative biotech play. CAMBRIDGE, Mass. Zhao, the Binance co-founder who goes by CZ, regularly promotes the asset class on television and social media, saying it has helped make him a billionaire.U.S. Last week, Kira announced the company completed a $53.5 million Series B+ financing to advance its LOGIC discovery platform and a pipeline of complement-targeted therapies. Its lead candidate, KB312, is a first-in-class, selective, immune-cell depleting monoclonal antibody which targets activated immune cells and aims to restore homeostasis through induction of immune tolerance. Open Map View. However, giving this thesis a second look, admittedly I gave little consideration to the possibility of investors “buying the rumor” as well as buying more on the news — if or when further developments come out regarding its vaccine catalyst. Among those asking questions about the firm’s compliance with rules is Coinbase. Cancer immunotherapy has reached a critical point, now that immune checkpoint inhibitors and two CAR-T products have received market approval in treating 16 types of cancers and 1 tissue-agnostic cancer indication. Under the $1.9 trillion relief bill known as the American Rescue Plan, any student debt wiped away through the end of 2025 wouldn’t be counted as income for tax purposes. Some taxpayers say the IRS ‘Get My Payment’ tool indicated that their third stimulus check was deposited into a wrong bank account that isn't theirs. Kira also announced plans to file three investigational new drug applications over the next 18 months. Outside of the vaccine candidate, the company has little else going for it that could help soften that potential blow. 1, there’s still a long road ahead for Ocugen when it comes to profiting off the Bharat vaccine. Kira Pharmaceuticals is a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases. It won’t take much to send it soaring again. )For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P. So, future developments with Covaxin need to go off without a hitch.InvestorPlace - Stock Market News, Stock Advice & Trading Tips In short, the long-term direction of this stock remains unclear. The 10-year rate has failed to close above 1.60% since early 2020, though it has surpassed that level in volatile intraday trading several times in recent weeks.“We’re talking about a fair amount of stimulus -- both fiscal and monetary -- going forward,” BTG Pactual Asset Management’s John Fath said, referring to the $1.9 trillion pandemic-relief bill and prospects for more, along with the Federal Reserve’s pledge to stay accommodative.